Moxetumomab pasudotox-tdfk Intravenous and Nelarabine Intravenous
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Nelarabine Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: nelarabine
Brand name: Arranon
Synonyms: Nelarabine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Nelfinavir
- Moxetumomab pasudotox-tdfk Intravenous-Nelfinavir Mesylate
- Moxetumomab pasudotox-tdfk Intravenous-Nelfinavir Oral Powder
- Moxetumomab pasudotox-tdfk Intravenous-Nelfinavir Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Nembutal
- Moxetumomab pasudotox-tdfk Intravenous-Nembutal Sodium injection
- Nelarabine Intravenous-Moxifloxacin
- Nelarabine Intravenous-Moxifloxacin (Systemic)
- Nelarabine Intravenous-Moxifloxacin Hydrochloride
- Nelarabine Intravenous-Moxifloxacin Injection
- Nelarabine Intravenous-Moxifloxacin Intravenous
- Nelarabine Intravenous-Moxifloxacin Tablets